Physician profile
Aftab Husain
NPI 1235131616
$4,328.45
in general payments reported to CMS, 2019-2025
18 companies · $90.00 in 2025
The $90.00 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $258 · 2021: $178 · 2022: $1,551 · 2023: $418 · 2024: $1,279 · 2025: $90.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883 · Travel and Lodging: $558 · Education: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.39 |
| Travel and Lodging | $558.05 |
| Education | $345.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,459.40 | 2022-2025 | Urolift |
| Astellas Pharma US INC | $624.53 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $583.62 | 2019-2024 | Erleada |
| Endo Pharmaceuticals INC. | $160.23 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $101.31 | 2023-2025 | Orgovyx |
| Pfizer INC. | $86.81 | 2020-2025 | |
| Abbvie INC. | $77.71 | 2019-2024 | |
| Myovant Sciences INC. | $52.49 | 2021-2022 | |
| Vertos Medical, INC. | $39.41 | 2019 | |
| Laborie Medical Technologies Corp. | $25.38 | 2023 | |
| Verity Pharmaceuticals INC. | $18.38 | 2021 | |
| Antares Pharma, INC. | $17.79 | 2025 | Xyosted |
| Olympus America INC. | $14.92 | 2022 | |
| Boston Scientific Corporation | $14.37 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.93 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.28 | 2019 | |
| 180 Medical, INC. | $12.75 | 2019 | |
| Currax Pharmaceuticals LLC | $12.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aftab Husain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.